Jan 11 (Reuters) - IMMUNOVIA AB (PUBL):
* ‍SIGNED A LETTER OF INTENT FOR COLLABORATION WITH DANISH CENTER FOR STRATEGIC RESEARCH INTO TYPE 2 DIABETES​
* ‍INTENTION IS DD2 CENTER WILL BE PART OF GROUNDBREAKING PANDIA-1 PROSPECTIVE STUDY INTO NEW ONSET TYPE 2 DIABETICS​
* IMMUNOVIA ACCELERATES PANCREAS CANCER STUDY OF NEW ONSET DIABETICS BY ADDING DENMARK‘S DIABETES CENTER FOR STRATEGIC RESEARCH-DD2 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
Our Standards: The Thomson Reuters Trust Principles.